Over 90% of GLP-1 drugs on the market are sold by two companies: Novo Nordisk (maker of Ozempic and Wegovy) and Eli Lilly (maker of Mounjaro and Zepbound)
This continuous feedback loop allows us to make timely adjustments to your plan, helping you stay on track toward your goals
Studies show BPC-157 stabilizes existing vascular structures and modulates vascular tone via nitric oxide-mediated vasodilation, safeguarding tissues against ischemic damage during repair processes
Until then, the risks of unofficial supply far outweigh any potential benefit
To evaluate the impact of GLP-1 RAs on the metabolic profile, we analyzed the serial changes in levels of HbA1c, LDL, body weight, and SBP from different time periods
No heavy, greasy, or sugary meals late at night